0
Transplantation: Preconditions and Outcomes in Lung Transplantation |

Influence of Steroids Medication on Clinical Outcome of Lung Transplantation

Bo Young Lee, MD; Tae Sun Shim, MD; Kyung-Wook Jo, MD; Sang-bum Hong, MD
Author and Funding Information

Asan Medical Center, Seoul, Korea (the Republic of)


Copyright 2016, American College of Chest Physicians. All Rights Reserved.


Chest. 2016;150(4_S):1312A. doi:10.1016/j.chest.2016.08.1428
Text Size: A A A
Published online

Extract

SESSION TITLE: Preconditions and Outcomes in Lung Transplantation

SESSION TYPE: Original Investigation Poster

PRESENTED ON: Wednesday, October 26, 2016 at 01:30 PM - 02:30 PM

PURPOSE: Lung transplantation is an emerging therapeutic option for end-stage lung disease. While steroids are not absolutely contraindicated for lung transplantation candidates, previous guideline recommended to maintain prednisolone lower than 20mg if possible. However, since 2006, the recommended dose for steroids was disappeared from guidelines due to many controversial study results. Because, the cessation of steroids is not feasible in many patients with end-stage lung disease, the present study aimed to compare clinical outcomes of Lung transplantation patients according to their steroids use.

First Page Preview

View Large
First page PDF preview

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Acute Exacerbation of COPD*: Factors Associated With Poor Treatment Outcome
PubMed Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543